Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Clinical Research Services Consulting, Grand Marais, Minnesota 55604, USA.
Over 256 women, age 21 to 65, with acquired mixed female sexual disorders participated in a 16-week randomized, placebo-controlled, double-blind study of Zestra, a topical botanical preparation. Routine outcome instruments measured efficacy and safety. Zestra was well tolerated. The only significant safety finding was mild-to-moderate genital burning seen only in Zestra-treated subjects (14.6%). Zestra provided significant desire, arousal, and treatment satisfaction benefits for a broadly generalized group of women with sexual difficulties.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on